FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth
Greg N. Brooke, Rachel L. Culley, D. Alwyn Dart, David J. Mann, Luke Gaughan, Stuart R. McCracken, Craig N. Robson, Bradley Spencer-Dene, Simon C. Gamble, Sue M. Powell, Robin Wait, Jonathan Waxman, Marjorie M. Walker, Charlotte L. Bevan
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth'. Together they form a unique fingerprint.